Beruflich Dokumente
Kultur Dokumente
drugs
Nitrofuran derivatives
Common
properties of SA:
- Sulfa nucleus;
- Mechanism of
action;
- Spectrum of
antibacterial action.
Prevention of crystalluria:
- Drink plenty of liquids (3-5 liters per day);
- drink alkaline mineral water or milk during SA using.
SALAZOSULFOPIRIDIN
SALAZOPIRIDAZIN
Mechanism of action:
block the enzyme DNA-gyrase, responsible for supercoiling of
the DNA molecule, as well as block the enzyme topoisomerase
type 4, is responsible for the compact folding of the DNA
molecule. This leads to an uncoiling of DNA and the
microorganism death.
Side effects:
Excitation of the central nervous system, anxiety, in large
doses - convulsions (disrupt the synthesis of GABA in the
CNS).
Dyspepsia, drug-induced hepatitis, swelling of the tongue
Tachycardia, shortness of breath
Anemia, leukopenia
Photodermatitis, itching
Disturbances of cartilage in children, so containdicated
for children under 12 years.
Hypothyroidism
Allergic reactions
Naphthalidine Derivatives
nalidixic acid
oxolinic acid
pipenamic acid
Naphthalidine Derivatives
The spectrum of action:
narrow (only Gr- microorganisms)
Mechanism of action:
blocks the enzyme DNA gyrase, as a consequence
despiralization DNA and death of microorganisms.
Indication:
when introduced into the body does not leave the
bloodstream, excrited with the urine in unchanged form,
so used in infectious diseases of the kidneys and urinary
tract infection (pyelonephritis, cystitis, urethritis,
prostatitis).
Type antimicrobial action:
Bactericidal
(Side effects see FLUOROQUINOLONES)
Nitrofurans
(classification)
1. The drug is used topically for treatment of wounds and hands, with
anaerobic infections:
FURACILLIN
FURAZOLIDONE
2. The drug is used in infectious diseases of the GIT:
FURAZOLIDONE
3. The drug is used in infectious diseases caused by protozoa:
FURAZOLIDONE
4. The drug is used in infectious diseases of the kidneys and urinary
tract:
FURAGIN
FURADONIN
SOLOFUR
Nitrofurans
The spectrum of action:
Gr +, protozoa
and anaerobic.
Mechanism of action:
are acceptors of H+ ions and enter into competition
with the natural acceptors in the chain of tissue
respiration, as a consequence of violating the
microbial cell respiration and death.
Mechanism of action:
Disrupt the synthesis of NA in the microbial cell;
Uncouple oxidative phosphorylation processes;
Communicating with iron enzymes and break breathing
activity of microbial cells;
All this leads to the death of microorganisms.
bactericidal
Indication:
see. classification
Derivatives of 8-oxyquinoline
Side effects:
Allergic reactions
Imidazole derivatives
Metronidazole
Tinidazole
Imidazole derivatives
The spectrum of action:
anaerobes, Giardia, amoeba, balantidiums, some
protozoa, Helicobacter pilory
Mechanism of action:
penetrate into the cells, where the enzymatic action of
metalloproteases separates nitro from them, which
causes the death of the microorganism.
Indication:
generalized anaerobic infection, amoebiasis, amoebic
dysentery, giardiasis, trichomoniasis, balantidiazis,
peptic ulcer and duodenal ulcer.
Imidazole derivatives
Side effects:
dalfopristin
Streptogramins
Isolated from Streptomyces pristinaespiralis
Used as oral agents in France since the 1960s
Dalfopristin and quinupristin are the only parentral
agents
The combination product (Synercid®) has up to 16 times
the activity of each agent alone
Streptogramins inhibit bacterial protein synthesis by
irreversibly blocking ribosome functioning
Each component is bacteriostatic but the combination is
bacteriocidal
The main reason for development and approval is VRE
Synercid™
Synthetic antibiotics
One approved (Linezolid), some are still
investigational (Eperezolid, furazolidone)
Linezolid
Linezolid
Approved for use in adults April 2000 and for
pediatrics December 2002
Works against aerobic gram-positive organisms
Linezolid inhibits bacterial protein synthesis by
interfering with translation
binds to a site on the bacterial 23S ribosomal
RNA of the 50S subunit; this action prevents the
formation of a functional 70S initiation complex,
an essential step in the bacterial translation
process
Linezolid
Linezolid is administered by intravenous infusion
or orally
oral bioavailability for linezolid is 100%.
have significant penetration into bone, fat,
muscle, and hematoma fluid
metabolism is non-enzymatic and does not
involve CYP450
does not inhibit or induce CYP450 isoenzymes.
Non-renal clearance accounts for 65% of an
administered linezolid dosage (no adjustment in
renal failure)
Indications of Linezolid